KATHY NGUYEN: Open Payments
NPI 1700459583 · CONCORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,919 in 66 payments from 25 companies in 2025. Trend: 2023 $377 · 2024 $983 · 2025 $1,919
Food & beverage: $1,799Education: $120
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $465 |
| ABBVIE INC. | 8 | $287 |
| Sumitomo Pharma America, Inc. | 6 | $233 |
| Olympus America Inc. | 2 | $146 |
| Antares Pharma, Inc. | 6 | $104 |
| UROGEN PHARMA, INC. | 4 | $86 |
| Verity Pharmaceuticals Inc. | 3 | $69 |
| PFIZER INC. | 3 | $62 |
| AngioDynamics, Inc. | 1 | $44 |
| COLOPLAST CORP | 2 | $40 |
Products named: ERLEADA, GEMTESA, BOTOX, RYBREVANT, iTIND System, XYOSTED, LUPRON DEPOT, Rubraca.
Industry payments across CA — which companies pay providers there.
